Pemphigus Vulgaris
What's New
Last Posted: Oct 05, 2024
- HLA-Cw6 Polymorphism in Autoimmune Blistering Diseases.
Christian Ciolfi, et al. Biomolecules 2024 0 (9) - Unraveling the role of the vitamin D-VDR pathway in pemphigus vulgaris from Tunisian patients.
Fatma Dhaffouli, et al. Steroids 2024 0 109454 - Assessing ST18 gene polymorphisms (rs17315309, rs2304365) in Iraqi patients with Pemphigus vulgaris.
Zahra Ali Al-Hasnawi, et al. Journal of medicine and life 2024 0 (1) 81-86 - HLA class II antigens in Croatian patients with pemphigus vulgaris and their correlation with anti-desmoglein antibodies.
Ines Lakoš Juki?, et al. Frontiers in immunology 2023 0 1200992 - Patient genetics shape the autoimmune response in the blistering skin disease pemphigus vulgaris.
Baker John, et al. Frontiers in immunology 2023 0 1064073 - Relationship between pemphigus and American tegumentary leishmaniasis: insights from serological and genetic profiles.
Walsh Priscilla, et al. Transactions of the Royal Society of Tropical Medicine and Hygiene 2017 0 (8) 345-353 - NUDT15 polymorphism and severe azathioprine-induced myelosuppression in a Chinese man with pemphigus vulgaris.
Yan W, et al. The British journal of dermatology 2017 0 (1) e40-e41 - Azathioprine-induced myelosuppression in two pemphigus vulgaris patients with homozygous polymorphism of NUDT15.
Shih Yen-Chi, et al. The Journal of dermatology 2018 0 (2) e59-e61 - Pemphigus vulgaris in two pairs of siblings from two unrelated Italian families: Human leukocyte antigen genotypes, ST18 mutation and immunological profile.
Fania Luca, et al. The Journal of dermatology 2020 0 (2) 211-214 - Novel HLA alleles associated with pemphigus vulgaris in Indian population detected by DNA microarray analysis.
Handa Sanjeev, et al. Indian journal of dermatology, venereology and leprology 2021 0 (6) 867-869
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: